Cardiotube Interview: LBCT: Trisol Early Feasibility Study Outcomes Including Patients With Reduced RV Function

Sunday, March 8, 2026

9:00 AM - 9:15 AM EST

Location: Lobby Level - Next to Speaker Ready

Interviewer(s)

Brian C. Case, MD

Interventional Cardiologist; Assistant Professor of Medicine, Georgetown University; Director of Cath Lab, Chief of Interventional Cardiology, MedStar Southern Maryland Hospital
MedStar Heart and Vascular Institute
Bethesda, Maryland, United States

Disclosure(s): Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Interviewee(s)

Kashish Goel, MD

Director, Transcatheter Heart Valve Interventions
Vanderbilt University Medical Center
Nashville, Tennessee, United States

Disclosure(s): Abbott: Grant/Research Support (Ongoing); Laplace: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Disclosure(s):

Brian C. Case, MD: Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Kashish Goel, MD: Abbott: Grant/Research Support (Ongoing); Laplace: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)